TY - JOUR
T1 - Consideration of the pH-dependent inhibition of dihydrofolate reductase by methotrexate
AU - Cannon, William R.
AU - Garrison, Barbara J.
AU - Benkovic, Stephen J.
N1 - Funding Information:
We are indebted to J. A. McCammon for providing the UHBD program, J. Antosiewicz for providing programs and files necessary for carrying out the titration calculations, and M. K. Gilson, J. M. Briggs and B. Honig for helpful suggestions. This work was supported by grants NIH GM24129 (S. J. B.) and NSF CHE-9317429 (B. J. G.). W. R. C. is a NIH postdoctoral fellow.
PY - 1997/8/29
Y1 - 1997/8/29
N2 - Poisson Bultzmann calculations were used to determine the pK(a) of protein functional groups in the unliganded dihydrofolate reductase enzyme, and the pK(a) of protein and ligand groups in methotrexate-enzyme complexes. The results reported here are in conflict with two fundamental tenets of dihydrofolate reductase inhibition by methotrexate: (1) Asp27 is not expected to be protonated near pH 6.5 in the apoenzyme as previously proposed based on fitting of empirical equations to binding data, and (2) the calculated pK(a) for the pteridine N1 of the inhibitor while bound to the protein is significantly lower than that estimated for this group from interpretation of NMR data (> 10). In fact, the electrostatic calculations and complementary quantum chemical calculations indicate that Asp27 is likely protonated when methotrexate is bound, resulting in a neutral dipoledipole interaction rather than a salt-bridge between the enzyme and the inhibitor. Reasons far this discrepancy with the experimental data are discussed. Furthermore, His45 and Glu17 in the Escherichia coli enzyme are proposed to be in part responsible for the pH dependence of the conformational degeneracy in the inhibitor-enzyme complex.
AB - Poisson Bultzmann calculations were used to determine the pK(a) of protein functional groups in the unliganded dihydrofolate reductase enzyme, and the pK(a) of protein and ligand groups in methotrexate-enzyme complexes. The results reported here are in conflict with two fundamental tenets of dihydrofolate reductase inhibition by methotrexate: (1) Asp27 is not expected to be protonated near pH 6.5 in the apoenzyme as previously proposed based on fitting of empirical equations to binding data, and (2) the calculated pK(a) for the pteridine N1 of the inhibitor while bound to the protein is significantly lower than that estimated for this group from interpretation of NMR data (> 10). In fact, the electrostatic calculations and complementary quantum chemical calculations indicate that Asp27 is likely protonated when methotrexate is bound, resulting in a neutral dipoledipole interaction rather than a salt-bridge between the enzyme and the inhibitor. Reasons far this discrepancy with the experimental data are discussed. Furthermore, His45 and Glu17 in the Escherichia coli enzyme are proposed to be in part responsible for the pH dependence of the conformational degeneracy in the inhibitor-enzyme complex.
UR - http://www.scopus.com/inward/record.url?scp=0030875357&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030875357&partnerID=8YFLogxK
U2 - 10.1006/jmbi.1997.1173
DO - 10.1006/jmbi.1997.1173
M3 - Article
C2 - 9281432
AN - SCOPUS:0030875357
SN - 0022-2836
VL - 271
SP - 656
EP - 668
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 4
ER -